Advertisement for orthosearch.org.uk
Results 1 - 12 of 12
Results per page:
Orthopaedic Proceedings
Vol. 104-B, Issue SUPP_11 | Pages 51 - 51
1 Nov 2022
Jagadeesh N Pammi S Kariya A Sales R
Full Access

Abstract. Background. The primary objective of the study is to determine the function outcome and survivorship of patellofemoral replacement. The secondary aim is to find the determinants of successful/poor outcome. Methods. This retrospective study involved 45 patients who underwent AVON patellofemoral replacement between January 2015 to December 2020 with the minimal follow-up off for 12 months. The functional outcome was measured using Oxford Knee score (OKS), EuroQol five dimension (EQ-5D). IWANO and Kellgren-Lawrence classification was used to analyse radiographs. To identify determinants of outcome, the following subgroups the presence or absence of normal alignment, tibiofemoral arthritis, trochlear dysplasia and previous surgery. Complications and revision rates were also recorded. Results. The mean follow-up period was 41.7 +/− 8.3 months with no patients lost in follow-up. Patellofemoral replacement significantly improved the Oxford Knee score (OKS), EuroQol five dimension (EQ-5D) (p<0.001). Four out of 45(8.9%) patients underwent revision surgery. Patients with normal alignment preoperatively did worse than those with abnormal alignment with patellar instability. Patients with grade two tibiofemoral arthritis, history of previous surgery did significantly worse with poorer functional outcome. Conclusion. Patellofemoral arthroplasty is reliable treatment option which improves patient function and quality of life with good survivorship in isolated patellofemoral arthritis in mid-term follow-up


Orthopaedic Proceedings
Vol. 100-B, Issue SUPP_10 | Pages 81 - 81
1 Jun 2018
Gonzalez Della Valle A
Full Access

Despite the successful, durable results, concern remains for using TKA in patients with isolated patello-femoral OA, as it requires an extensive surgical exposure and bone resection, a long recovery time, and a potentially more complex revision than that required for a patient with a failed patello-femoral arthroplasty (PFA).

PFA was introduced in the late 1970s. While PFA was successful in providing pain relief, the procedure did not gain widespread use because of initial design limitations that predisposed to PF maltracking, catching, and subluxation. The mechanical complications associated with first-generation PFA offset the potential advantages of maintaining the knee's native soft tissues and spurred efforts to improve implant design, and to refine surgical techniques and patient selection.

Over the past two decades, second generation PFAs incorporated changes in implant design and instrumentation and have shown promising results when used in the properly selected patient population. In addition, with improved instrumentation and robotics, adequate implant alignment and rotation can be achieved in the majority of patients, including those with severe patellofemoral dysplasia.

Our meta-analysis of TKA and PFA for the treatment of isolated patello-femoral OA showed that the rate of complications of patients undergoing PFA was 30% after a median follow up of 5.3 years, which is significantly higher than the 7% rate of complications in patients who underwent TKA. The most frequent type of complication associated with PFA was mechanical (including loosening and instability), which is consistent with the malalignment and maltracking-related failures previously reported. The incidence of re-operation after PFA (21%) was significantly higher than that seen after TKA (2%). The most frequent indication for re-operation after PFA was mechanical failure (7%), followed by progression of OA (6%), and persistent pain or stiffness (5%). The most common re-operations after PFA were conversion to TKA, revision of PFA components, lateral releases, open or arthroscopic debridement, manipulations under anesthesia, and bony and/or soft tissue extensor mechanism re-alignment procedures. In our study, 11% of patients treated with PFA underwent a revision arthroplasty, with 4% undergoing revision PFA and 7% undergoing conversion to TKA.

Our comparison of patients who were treated with second-generation PFA designs versus TKA showed no difference in the rate of complications, re-operation, or revision arthroplasty. Additionally, length of follow-up did not significantly influence any of these outcomes when comparing second-generation PFA and TKA.

These observations provide support for the use of current PFA designs. The mechanical complications and subsequent re-operations that affected first-generation PFA designs appear to be of less concern with proper patient selection, meticulous surgical technique, current implant designs and peri-operative care. While it is difficult to predict the survivorship of current PFA designs, it is our expectation that patient selection will continue to be a critical component in determining long-term results. The potential benefit of providing pain relief while preserving the tibiofemoral articulations makes PFA a promising treatment option.


Orthopaedic Proceedings
Vol. 98-B, Issue SUPP_22 | Pages 73 - 73
1 Dec 2016
Lonner J
Full Access

Introduction

Epidemiologic studies indicate that isolated patellofemoral (PF) arthritis affects nearly 10% of the population over 40 years of age, with a predilection for females. A small percentage of patients with PF arthritis may require surgical intervention. Surgical options include non-arthroplasty procedures (arthroscopic debridement, tibial tubercle unloading procedures, cartilage restoration, and patellectomy), and patellofemoral or total knee arthroplasty (PFA or TKA). Historically, non-arthroplasty surgical treatment has provided inconsistent results, with short-term success rates of 60–70%, especially in patients with advanced arthritis. Although TKA provides reproducible results in patients with isolated PF arthritis, it may be undesirable for those interested in a more conservative, kinematic-preserving approach, particularly in younger patients, who may account for nearly 50% of patients undergoing surgery for PF arthritis. Due to these limitations, patellofemoral arthroplasty (PFA) has become utilised more frequently over the past two decades.

Indications for PFA

The ideal candidate for PFA has isolated, non-inflammatory PF arthritis resulting in “anterior” pain and functional limitations. Pain should be retro- and/or peri-patellar and exacerbated by descending stairs/hills, sitting with the knee flexed, kneeling and standing from a seated position. There should be less pain when walking on level ground. Symptoms should be reproducible during physical examination with squatting and patellar inhibition testing. An abnormal Q-angle or J-sign indicate significant maltracking and/or dysplasia, particularly with a previous history of patellar dislocations. The presence of these findings may necessitate concomitant realignment surgery with PFA. Often, patients with PF arthritis will have significant quadriceps weakness, which should be treated with preoperative physical therapy to prevent prolonged postoperative pain and functional limitations. Tibiofemoral joint pain suggests additional pathology, which may not be amenable to PFA alone.


Orthopaedic Proceedings
Vol. 97-B, Issue SUPP_1 | Pages 78 - 78
1 Feb 2015
Hofmann A
Full Access

Isolated patellofemoral arthritis is not an uncommon problem, with no clear consensus on treatment. Nonoperative and many forms of operative treatments have failed to demonstrate long-term effectiveness in the setting of advanced arthritis. Total knee arthroplasty (TKA) has produced excellent results, but many surgeons are hesitant to perform TKA in younger patients with isolated patellofemoral arthritis. In properly selected patients, patellofemoral arthroplasty (PFA) is an effective procedure with good long-term results. Contemporary PFA prostheses have eliminated many of the patellar maltracking problems associated with older designs, and short-term results, as described here, are encouraging. Long-term outcome and prospective trials comparing TKA to PFA are needed.


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXV | Pages 148 - 148
1 Jun 2012
Mofidi A Badaja S Holt M Davies A
Full Access

The aim of this study was to assess the increase in the anterior diameter of the knee and the impact of this increase on the range of motion and function of the knee.

Twenty-eight patients (34 knees) who underwent Patello-femoral replacement with FPV (Wright Medical) prosthesis between 2005 and 2009 who were identified retrospectively and analyzed using chart and radiological review. Oxford and AKSS knee-scores were gathered prospectively pre-operative and at follow-up.

Trochlear height was measured using lateral radiograph. Trochlear height was compared pre and postoperatively. Patellar height was also measured in preoperative and postoperative skyline view and was compared. The range of movement at six weeks and the Oxford and American knee society knee scores at six months postoperatively were noted. Association between increased anterior height and improved range of motion was studied.

All but three-knees regained full knee extension. Postoperative mean range of flexion of the knee joint was 116 degrees. The mean Oxford knee and the mean American Knee Society Knee Scores significantly improved post-operatively

The trochlear height was increased by 4mms. Patellar height was also increased by 3 mms resulting in average total increase of 7 mms in the anterior-posterior diameter of the knee. We found no relationship between range of motion of the knee and the increase in the anterior-posterior diameter. We found a negative correlation between increase in the antero-posterior and preoperative trochlear and patellar height.

We conclude that FPV Patello-femoral replacement results in correct anatomical reconstruction of the trochlear height rather than ‘overstuffing’ of the patellofemoral joint which can lead to stiffness and failure of resolution of pain post-operatively. This should in turn result in durable improvements in pain and function.


Orthopaedic Proceedings
Vol. 95-B, Issue SUPP_1 | Pages 77 - 77
1 Jan 2013
Isaac S Shyamsunder S Palan J Esler C
Full Access

Introduction

The optimal treatment for isolated patello-femoral arthritis is unclear. Patello-femoral arthroplasty (PFA) may offer superior knee function in isolated patello-femoral osteoarthritis compare to TKA. The literature is controversial for patient outcomes in PFA. Some reports showed improved outcomes while others were disappointing. We assessed our outcomes to try to identify causes for poor outcomes.

Methods

The Trent Arthroplasty was established in 1990 to collect prospective data on knee arthroplasty surgery. Data is entered by surgeons at the time of surgery, with patient consent. PFA constitute less than 1% of the arthroplasties performed in this region. Patients were sent self-administered outcome forms 1 year post-op. Re-operation and revision procedures were reported. 334 PFA have been registered from 17 hospitals. 79% were female patients with 43% of the patients aged 55 years or less, suggesting dysplasia as the cause of their osteoarthritis. Age range 28–94 yrs (SD 11.8 yrs). The implants were Stryker Avon 236, Corin Leicester 47, Link Lubinus 24, Smith & Nephew Journey 10, DePuy LCS 7, Wright FPV 2, other 8.


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XVII | Pages 6 - 6
1 May 2012
Lewis J Arasin S Padgett J Davies A
Full Access

Patellofemoral unicompartmental joint replacement is a controversial subject with a relatively small evidence base. Of the 50,000 total knee arthroplasties performed each year in the UK, approximately 10% are performed for predominantly patellofemoral arthritis. There are several patellofemoral unicompartmental prostheses on the market with the National Joint Registry recording 745 such prostheses used in 2007. Most evidence in favour of this procedure comes from experience with the Avon prosthesis (Stryker) predominantly from designer-surgeons. The FPV patellofemoral joint replacement (Wright Medical) has been in use in Europe for several years. The instruments have recently been redesigned and the device marketed in the UK. In 2007 the FPV had 5.9% market share (n=44). We present our early experience with the FPV patellofemoral joint replacement, which to our knowledge, is the first clinical outcome series for this prosthesis. 33 consecutive FPV joint replacements in 29 patients were performed between April 2007 and September 2009 for unicompartmental patellofemoral OA. All cases were performed or directly supervised by the senior author. Results are presented with a minimum follow-up of six months. Oxford and American Knee Society scores (AKSS) were obtained on all patients preoperatively and at subsequent outpatient visits. Mean preoperative AKSS knee score was 49.7 points and postoperative scores at 6 months and 1 year were 82.5 and 86.4 respectively. Mean Oxford score preoperatively was 30.4 (37%) and at 6 months and 1 year were 21.3 (56%) and 11.2 (77%) respectively. There were no complications related to the implant. One knee required a secondary open lateral release due to inadequate balancing at the index procedure. Further medium to long-term follow up data are required, but our initial experience with this device is encouraging


Orthopaedic Proceedings
Vol. 98-B, Issue SUPP_8 | Pages 29 - 29
1 May 2016
Harris S Iranpour F Riyat H Cobb J
Full Access

Introduction. The trochlea of a typical patellofemoral replacement or anterior flange of a total knee replacement usually extends past the natural trochlea and continues onto the femoral anterior cortex. One reason for this is that it allows a simple patella button to be permanently engaged in the trochlea groove in an attempt to ensure stability. On the natural patella, the apex helps to guide it into the trochlea groove as the knee moves from full extension into flexion. The aim is to study whether a generalised patella can be created that is close in form to a healthy patella. Method. MRI scans were taken of 30 patellae. Characteristics of these patellae (height, width, thickness, apex angle) were measured. The apex angle was found to be similar between patellae (mean=126 degrees, sd = 8.8), as were the ratios between height and width (mean width/height = 1.05, sd = 0.07) and between thickness and width (mean width/thickness = 1.8, sd = 0.19). These patellae were then segmented to create a surface including cartilage, resulting in 30 STL (stereolithography) files in which the surfaces are represented by triangle meshes. To design the average patella the individual patellae were aligned to a standard frame of reference by placing a set of landmarks on the proximal/distal, medial/lateral and anterior/posterior extents of each (fig.1). The vertical axis was defined as passing parallel to the proximal/distal points and the horizontal as passing parallel to the medial/lateral points when looking along the computed vertical axis. The origin centre of the frame of reference was chosen to be mid-way between these points. The mean width was then computed and each patella scaled linearly around the origin to give them all equal width. All the aligned patellae were then averaged together to provide a composite cartilaginous patella. The averaging process was achieved by taking one patella as a seed. The patella chosen for seed was that whose parameters were closest to the average width, height and thickness. An approximately normal vector was passed a point ‘P’ on the seeds, and the points at which these intersected the other models were then determined. The closest intersection point to ‘P’ on each model was chosen and these averaged together. ‘P’ is then replaced in the model with this average point. The averaging process then continues with all the remaining points on the seed model in the same manner to build the average models. Results and Discussion. The mean patella was compared with individual patellae. This comparison was performed by taking each point on the mean patella and finding the closest point on individual patellae - a colour coded map of differences was obtained (fig.2) along with a mean of the absolute difference for each patella. The absolute mean difference ranged from 0.56mm to 1.33mm, averaging at 0.85mm. This shows a reasonable fit between the average patella and each individual example, raising the possibility of using the average shape in future research to develop anatomical patellofemoral replacements and for planning patella resurfacing


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XL | Pages 74 - 74
1 Sep 2012
Innocenti B van Jonbergen H Labey L Verdonschot N
Full Access

INTRODUCTION. Patellofemoral joint (PFJ) replacement is a successful treatment option for isolated patellofemoral osteoarthritis. With this approach only the involved joint compartment is replaced and the femoro-tibial joint remains intact. Minimizing periprosthetic bone loss, which may occur due to the stress shielding effect of the femoral component, is important to insure long-term outcomes. The objective of this study was to investigate, using finite element analyses, the effects of patellofemoral replacement on the expected stress distribution of the distal femur eventually leading to changes in bone density. METHODS. MRI images of a healthy knee were acquired, segmented and reconstructed into a 3D physiological model of the bony and cartilaginous geometries of distal femur and patella with patellar tendon and insertion of the quadriceps tendon. This model was modified to include PFJ replacements with either a Journey PFJ or a Richards II PFJ prosthesis, and a Genesis II TKA (Smith&Nephew, Memphis, TN). The prosthetic components were incorporated in the intact model based on the manufacturer's instructions or previously described surgical techniques (Figure 1). Cortical bone was modeled with orthotropic properties, while homogeneous linear isotropic elasticity was assumed for trabecular bone, cartilage, cement and femoral components materials. The patellar tendon was given Neo-Hookean behavior. UHMWPE patellar buttons for all designs were assigned non-linear elasto-plastic material. The simulated motion consisted of a 10 second loaded squat, starting from 0° until a flexion angle of 120° matching experimental kinematics tests performed in previous in-vitro analysis on physiological cadaveric legs [1-2]. The patella model was constrained fixing the distal part of the patellar ligament and applying a quadriceps force distributed on the quadriceps insertion on the proximal surface of the patella. During the dynamic simulation the average Von Mises stress was calculated in two regions of interest (ROI) defined in the femoral bone: one anterior and one proximal. The location of the ROIs was defined to fit the same regions as used in a previous bone mineral density analysis following patellofemoral arthroplasty (height 1cm, length 1cm). RESULTS AND DISCUSSION. Overall, the average bone stresses in both ROIs increased with flexion angle. Maximal stresses during squat were reached at 90° flexion angle, (2.8–3.8 MPa for the anterior ROI and 1.4–1.6 MPa for the proximal ROI). Mean stresses in the proximal ROI were similar for both PFJ designs and the physiological model, and slightly lower for the TKA. Between 80° and 120°, anterior ROI bone stresses for Journey PFJ design were comparable to the physiological knee, while reduced by almost 25% for the other designs (Figure 1). These results suggest a different stress-shielding behavior depending on design geometry and material properties. CONCLUSIONS. This study evaluated periprosthetic bone stress distributions of different patellofemoral replacements. The numerical analyses of physiological and replaced knee models predicted a decrease in stress behind the anterior flange of the femoral component for some designs. This reduction was dependent on prosthesis design geometry and materials properties


Orthopaedic Proceedings
Vol. 97-B, Issue SUPP_1 | Pages 79 - 79
1 Feb 2015
Thornhill T
Full Access

It is important to remember that osteoarthritis is a noninflammatory condition that can affect 1, 2 or all 3 compartments of the knee. Moreover, this disease is a continuum from very mild to very severe involvement of the soft tissue, articular cartilage and bone. For this reason, a variety of nonsurgical and surgical options are indicated. The rheumatologist and/or orthopedist must understand the stage of the disease and fit that both to the pathology, age, activity level, and functional needs of the patient. For that reason, each of the options discussed today have an indication. The important issue about tricompartmental replacement is that we have improved technology and technique and the indications of today are broader than those of 20 years ago. Hopefully, they will continue to evolve both in terms of materials and instruments. The American Rheumatologic Association (ARA) has stated that joint replacement has been the major improvement in the care of the arthritic patient. The tricompartmental solution is the treatment of choice in patients with inflammatory arthritis such as rheumatoid arthritis as well as the solution in osteoarthritic patients with tricompartmental disease. There is an indication for osteotomy, unicompartmental replacement and perhaps patellofemoral replacement. I think the next frontier will be to find disease modifying osteoarthritic drugs (DMOADS) that will provide disease intervention as the DMARDs have done in rheumatoid arthritis. Moreover, cartilage repair combined with osteotomy will hopefully allow us to prevent progression of this disease


Orthopaedic Proceedings
Vol. 97-B, Issue SUPP_13 | Pages 57 - 57
1 Nov 2015
Berend K
Full Access

To progress to a same day surgery program for arthroplasty, it is important that we examine and resolve the issues of why patients stay in the hospital. The number one reason is fear and anxiety for the unknown and for surgical pain. The need for hospital stay is also related to risk arising from comorbidities and medical complications. Patients also need an extended stay to manage the side effects of our treatment, including after-effects of narcotics and anesthesia, blood loss, and surgical trauma. The process begins pre-operatively with an appropriate orthopaedic assessment of the patient and determination of the need for surgery. The orthopaedic team must motivate the patient, and ensure that the expectations of the patient, family and surgeon are aligned. In conjunction with our affiliated hospitalist group that performs almost all pre-admission testing, we have established guidelines for patient selection for outpatient arthroplasty. The outpatient surgical candidate must have failed conservative measures, must have appropriate insurance coverage, and must be functionally independent. Previous or ongoing comorbidities that contraindicate the outpatient setting include: cardiac – prior revascularization, congestive heart failure, or valve disease; pulmonary – chronic obstructive pulmonary disease, or home use of supplemental oxygen; untreated obstructive sleep apnea – BMI >40 kg/m2; renal disease – hemodialysis or severely elevated serum creatinine; gastrointestinal – history or post-operative ileus or chronic hepatic disease; genitourinary – history of urinary retention or severe benign prostatic hyperplasia; hematologic – chronic Coumadin use, coagulopathy, anemia with hemoglobin <13.0 g/dl, or thrombophilia; neurological – history of cerebrovascular accident or history of delirium or dementia; solid organ transplant. Pre-arthroplasty rehabilitation prepares the patient for peri-operative protocols. Patients meet with a physical therapist and are provided with extensive educational materials before surgery to learn the exercises they will need for functional recovery. Enhancement of our peri-operative pain management protocols has resulted in accelerated rehabilitation. The operative intervention must be smooth and efficient, but not hurried. Less invasive approaches and techniques have been shown to decrease pain, reduce length of stay, and improve outcomes, especially in the short term. In 2014, 385 primary partial knee arthroplasty procedures (7 patellofemoral replacement, 13 lateral, and 365 medial) were performed by the author and his 3 associates at an outpatient surgery center. Of those, 348 (95%) went home the same day while 17 (5%) required an overnight stay, with 11 for convenience related to travel distance or later operative time and 6 for medical issues. Outpatient arthroplasty is safe, it's better for us and our patients, and it is here now. In an outpatient environment the surgeon actually spends more time with the patients and family in a friendly environment. Patients feel safe and well cared for, and are highly satisfied with their arthroplasty experience


Bone & Joint 360
Vol. 1, Issue 5 | Pages 34 - 35
1 Oct 2012
Cobb JP